Home > Research > Publications & Outputs > Genetic and structural validation of Aspergillu...

Electronic data

  • Fang-MolMicro-2013

    Rights statement: © 2013 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Final published version, 984 KB, PDF-document

    Available under license: CC BY


Text available via DOI:

View graph of relations

Genetic and structural validation of Aspergillus fumigatus UDP-N-acetylglucosamine pyrophosphorylase as a potential antifungal target

Research output: Contribution to journalJournal article

  • Wenxia Fang
  • Ting Du
  • Olawale G. Raimi
  • Ramon Hurtado-Guerrero
  • Mick Urbaniak
  • Adel F. M. Ibrahim
  • Michael A. J. Ferguson
  • Daan M. F. van Aalten
<mark>Journal publication date</mark>08/2013
<mark>Journal</mark>Molecular Microbiology
Issue number3
Number of pages15
Pages (from-to)479-493
Early online date5/07/13
<mark>Original language</mark>English


The sugar nucleotide UDP-N-acetylglucosamine (UDP-GlcNAc) is an essential metabolite in both prokaryotes and eukaryotes. In fungi, it is the precursor for the synthesis of chitin, an essential component of the fungal cell wall. UDP-N-acetylglucosamine pyrophosphorylase (UAP) is the final enzyme in eukaryotic UDP-GlcNAc biosynthesis, converting UTP andN-acetylglucosamine-1-phosphate (GlcNAc-1P) to UDP-GlcNAc. As such, this enzyme may provide an attractive target against pathogenic fungi. Here, we demonstrate that the fungal pathogen Aspergillus fumigatus possesses an active UAP (AfUAP1) that shows selectivity for GlcNAc-1P as the phosphosugar substrate. A conditional mutant, constructed by
replacing the native promoter of the A. fumigatus uap1 gene with the Aspergillus nidulans alcA promoter, revealed that uap1 is essential for cell survival and
important for cell wall synthesis and morphogenesis.
The crystal structure of AfUAP1 was determined and revealed exploitable differences in the active site compared with the human enzyme. Thus AfUAP1 could represent a novel antifungal target and this work will assist the future discovery of small molecule inhibitors against this enzyme.

Bibliographic note

© 2013 The Authors. Molecular Microbiology published by John Wiley